Interleukin-2 (IL-2) is produced by T lymphocytes in response to activation. It is essential for T-cell proliferation and differentiation in vitro and has been implicated as an important regulator of immune responses (38) . Conclusive evidence for a modifying role for IL-2 in vivo is lacking. However, analysis of IL-2 production has been found relevant for several diseases in which a dysregulation of lymphocyte funciton is apparent. Impairment of IL-2 production has been detected in murine models of acute trypanosomiasis (11) , lethal malaria infection (21) , and histoplasmosis (42) and in patients with lepromatous leprosy (32) . Spleen cells from mice with acute Leishmania donovani infection have also been found to produce lower levels of IL-2 in vitro than were produced by normal spleen cells (36) . However, it remains unclear whehther suppressed IL-2 production plays a causal role in disease development or is merely a consequence of disease.
The spectrum of murine models reflects the range of clinical leishmaniasis and is amenable to genetic and immunological analysis (24, 29, 30) . BALB/c mice are extremely susceptible to Leishmania major in that the initial cutaneous lesion develops inexorably, leading to uniformly fatal disseminating and visceralizing disease, even with a minimal infective dose. It is now generally believed that the vulnerability of mice of BALB background to L. major infection is largely due to a non-H-2-linked autosomal gene, tentatively * Corresponding author.
named Scl (J. M. Blackwell, J. G. Howard, F. Y. Liew, and C. Hale, Mouse Newsl., 70:86, 1984) , which is expressed primarily in macrophages. The inability of macrophages to control initial replication of the parasite appears to lead to the preferential induction of specific suppressor T cells which prevent the generation of otherwise curative cellmediated immunity (9, 12) . The suppressor T cell precursors can be inhibited and the effector T cells can be strongly induced by subjecting the mice to sublethal (550 rads) irradiation shortly before infection. Such treatment precludes progresive lesion development, and the majority of mice achieve complete healing and are immune to further L. major infection (13) . Protective immunity has also been induced by prophylactic immunization with irradiated, killed, or disintegrated L. major promastigotes via intravenous (i.v.) or intraperitoneal routes but not by subcutaneous (s.c.) or intramuscular injections (14, 31) ; s.c. or intramuscular injections of the same promastigote antigens strongly impair the induction and expression of protective immunity resulting from i.v. immunization (23, 26) . Suppressive reactivity, convalescent immunity, acquired prophylactic immunity, and the inhibitory effect of s.c. injection can all be adoptively transferred by T cells bearing the Lyt-1+2-phenotype (22, 25, 26 Antigens. Formaldehyde-fixed (ff) promastigotes were prepared by incubating 2 x 108 parasites per ml in 0.5% Formalin for 5 min at room temperature. They were then washed four times in saline, suspended to 2 x 108 parasites per ml in saline, and stored at 4°C until used.
-y-Irradiation. Mice were irradiated by a cesium (137Cs) source at a rate of 50 rads/min (550 rads per dose) 4 h before infection. The promastigotes used for immunization were exposed to 150 kilorads of -y irradiation from the same source at 143.7 rads/min. After irradiation, the parasite suspension was stored at 4°C and used within 1 week.
Immunization. Mice were immunized i.v. or s.c. with four weekly doses of 2 x 107 irradiated promastigotes in 0.1 ml of phosphate-buffered saline.
Tissue culture medium. The tissue culture medium consisted of RPMI 1640 (Flow Laboratories, Herts, United Kingdom) supplemented with glutamine (2 mM), penicillin, streptomycin, 2-mercaptoethanol (50 ,uM), and 5 or 10% heat-inactivated FCS.
In vitro production of IL-1. Peritoneal cells (PC) were isolated by injecting 5.0 ml of cold culture medium into the peritoneal cavity and collecting the cells under sterile conditions. Lymphocyte proliferation assay. Spleen cells from donor mice were harvested, washed, and suspended to 107 or 106 cells per ml in culture medium, and 100 ,u was incubated with 100 ,ul of ff promastigotes (105) or ConA (1 ,ug/ml) for 72 h at 37°C in 5% CO2. The cultures were pulsed and harvested and the uptake of radioactivity was measured as described for the IL-1 assay.
Cell fractionation. Spleen cells from normal or infected BALB/c mice were fractionated by the following procedures.
(i) Antiimmunoglobulin column. The use of the antiimmunoglobulin column was described previously (12) . It reduces immunoglobulin-positive cells from 40 to 50% to less than 0.5% as assessed by an indirect immunofluorescence assay.
(ii) Sephadex G-10 column. The Sephadex G-10 column was prepared as described by Ly and Mishell (27) .
(iii) Plastic adherence. Unfractionated or immunoglobulinnegative spleen cells (2 x 107) were incubated in 5 ml of medium plus 20% FCS for 4 h in 100-mm plastic petri dishes (Falcon) at 37°C and 5% CO2. The dishes were precoated with FCS (2 h at 370C). Nonadherent cells were removed by VOL. 54, 1986 on November 6, 2017 by guest
vigorous shaking with three changes of warm medium. The adherent cells were detached by incubating the dishes with cold phosphate-buffered saline containing 0.2% EDTA and 5% FCS for 40 min at 4°C followed by vigorous pipetting.
(iv) Carbonyl iron. Sterilized carbonyl iron (100 mg) was added to 108 unfractionated or nonadherent spleen cells in 5 ml of medium. The mixture was incubated on a rocking platform at 37°C for 45 min. At the end of the incubation, the iron-containing cells were retained with a strong magnet.
(v) Anti-Thy-1.2 antibody plus complement. In some experiments, adherent cells were treated with anti-Thy-1.2 antibody (F7D5, monoclonal immunoglobulin M; Olac 1976, Ltd., Oxon, United Kingdom) and complement as described previously (26) .
Each of the cell fractions was stained with Giemsa solution and esterase (Sigma) by the method described by Tucker et al. (41), with oa-naphthyl acetate as the substrate.
Statistical analysis. All experiments were performed two to four times. Statistical significance (P < 0.05) was determined by Student's t test.
RESULTS
Production of IL-2 and IL-1 by cells from mice at various times after L. major infection. Groups of BALB/c mice were given four weekly i.v. or s.c. injections of 2 x 107 irradiated (150 kilorads) L. major promastigotes and then infected s.c. in the shaved rump with 2 x 107 viable promastigotes 7 days after the last injection. Another group was exposed to 550-rad whole-body irradiation and 4 h later, together with nonirradiated mice, infected similarly with 2 x 107 promastigotes. Normal BALB/c mice infected with 2 x 107 promastigotes developed progressive lesions leading to uniformly fatal disease, as demonstrated previously (12, 23) . Lesion development was arrested, with the majority achieving complete healing, when the mice were subjected to prior sublethal irradiation (Fig. 1) . Substantial resistance to infection was achieved with four i.v. immunizations, whereas 4 s.c. injections not only failed to induce protection but exacerbated lesion development.
At various intervals, groups of three mice were killed and tested for (i) the production of IL-2 by spleen cells in response to ConA (5 ,xg/ml) stimulation and (ii) the release of IL-1 by PC when activated by LPS (10 ,ug/ml).
(i) IL-2 production. Just before infection, spleen cells from mice given four s.c. injections produced significantly higher levels of IL-2 than did those from normal mice (Fig. 2) . However, this elevated IL-2 production was soon lost, as lesions progressed, and none was detectable after 100 days. Spleen cells from mice immunized four times i.v. produced IL-2 at a level similar to that of normal spleen cells. This increased from 60 days onward and was sustained at a level higher than that of normal spleen cells. Spleen cells from sublethally irradiated mice produced a significantly lower level of IL-2 22 days after irradiation and infection, but the level increased steadily as the lesion regressed and by day 80 became substantially higher than that of normal spleen cells. In contrast, spleen cells from normal mice infected with 2 x 107 promastigotes produced significantly lower levels of IL-2
at all the time points tested.
(ii) IL-1 production. During the early stages of infection, PC from all mice produced higher levels of IL-1 in response to LPS than did cells from the normal control animals (Fig.  3) . From day 60 onward, however, PC from mice immunized four times s.c. or i.v. produced IL-1 at levels similar to that of normal PC. PC from sublethally irradiated mice, on the other hand, maintained a significantly higher level of IL-1 production than the controls did throughout the experiment. In contrast, PC from untreated mice produced high levels of IL-1 between 60 and 80 days after infection, and the level returned to that of the normal controls at day 100.
Titration of IL-2 activity in culture supernatants of ConAstimulated spleen cells. Spleen cells from groups of mice 60 days after infection were stimulated with 5 ,ug of ConA per Fig. 2 ; the symbols are defined in the legend to Fig. 1 . The horizontal line represents the IL-1 activity produced by uninfected PC (controls). The vertical bars represent one standard error of the mean; n = 3.
ml, and the supematants were tested for IL-2 activity by using CTL cells. The culture supernatants of cells from mice immunized i.v. or s.c. or given prophylactic sublethal irradiation contained significant levels of IL-2, whereas little or no IL-2 activity was detected in the culture supernatant of cells from mice untreated before infection (Fig. 4) to ConA underwent significant proliferation in response to ff promastigotes, although at a lower level than did spleen cells from healed mice. As expected, normal spleen cells did not respond to ff promastigotes.
Response of spleen cells to exogenous IL-2. Since spleen cells from mice with progressive disease responded poorly to ConA activation, they were tested in the presence of exogenous IL-2. They were incubated for 48 h with 5 jig of ConA per ml, washed, and recultured with a constant amount of added IL-2. The ConA-activated spleen cells (ConA blasts) responded vigorously to exogenous IL-2, except those from mice infected 100 days earlier with L. major and suffering from progressive disease ( Table 2) . It should be noted that the ConA blasts from mice 23 days after infection were able to respond to added IL-2 and that the unresponsiveness did not occur until a later stage of infection.
Suppressive effect of spleen cells from mice with progressive disease. A possible suppressive effect of cells from mice with progressive disease on IL-2 production by cells from normal, cured, or immunized mice was examined. Spleen cells from mice infected 112 days earlier were cocultured with equal numbers of spleen cells from healed or immunized donors, and the supernatants, harvested 24 h later, were tested for IL-2 activity. Cells from mice with progressive lesions consistently suppressed IL-2 production by other spleen cell populations (Table 3) .
Cell-type analysis of IL-2 suppressive effect of spleen cells. (i) Depletion of adherent cells. Spleen cells from normal or infected mice were depleted of macrophages by plastic adherence, Sephadex G-10 column, and carbonyl iron treatments. The ability of residual nonadherent cells to produce IL-2 was tested in the standard assay. Unfractionated spleen cells from infected mice with progressive disease again produced significantly lower levels of IL-2 than did normal unfractionated spleen cells (Table 4 ). The suppression was significantly reduced, and in some cases IL-2 production was restored, after depletion of the adherent cells. This was particularly pronounced when the depletion was performed with a Sephadex G-10 column followed by carbonyl iron treatment. The plastic adherence and carbonyl iron procedure reduced the nonspecific esterase-positive cells in the spleen cell populations from 10 to 25% to 5 to 8%, and treatment with Sephadex G-10 and carbonyl iron reduced the level to 1 to 2%. It should be noted that at no time did the removal of adherent cells significantly alter the level of IL-2 produced by uninfected normal spleen cells.
(ii) Effect of adherent cells on IL-2 production by nonadherent cells. Having shown that the nonadherent spleen cells from infected mice could produce normal levels of IL-2 in the absence of adherent macrophages, we sought direct evidence for an IL-2 suppressive effect of the adherent cells. Spleen cells from normal and infected mice were fractionated into adherent and nonadherent cells. Control nonadherent cells from a normal spleen (NA-C) were cocultured in various ratios with adherent cells from uninfected (A-C) or infected (A-I) mice. IL-2 production by NA-C was significantly reduced in the presence of A-I compared with that in the presence of A-C (Table 5) . In all cases, the suppressive effect of A-I decreased as the NA-C/A-I ratio increased. Similar results were obtained with different cell-fractionating procedures and with A-I harvested 40 days after infection.
Effect of indomethacin on IL-2 production by spleen cells. It is well documented that activated macrophages release, among other materials, prostaglandins which may be responsible for the interference with IL-2 production by T cells. a Pooled spleen cells from four to eight normal or infected mice (63 to 105 days postinfection) were left unfractionated or were depleted of adherent cells by plastic adherence followed by carbonyl iron treatment or by passage through a Sephadex G-10 column followed by carbonyl iron treatment. Both the fractionated and unfractionated cells were cultured at 107 cells per ml with 5 p.g of ConA per ml for 24 h, and the supernatants were assayed for IL-2 activity in triplicate with Experiments were performed to test the production of IL-2 by spleen cells in the presence of various concentrations of indomethacin. Whereas indomethacin (1 to 10 ,ug/ml) had no effect on IL-2 production by normal spleen cells, it significantly increased the production of IL-2 by unfractionated spleen cells from mice with progressive disease (Fig. 5) .
DISCUSSION
It is generally accepted that cell-mediated immunity plays a causal role in recovery from leishmanial infection (29, 30) and that the failure of highly susceptible mouse strains of BALB background to contain cutaneous leishmaniasis is attributable to suppression of such curative immunity (13, 24) . Two distinct forms of immune suppression have been identified: (i) antigen-specific T cell-mediated suppression (13) and (ii) adherent-cell (macrophage)-mediated nonspecific suppression of the mitogen-induced or antigen-activated proliferative response (37) . The mechanism of suppression is unclear in both cases. It has also been postulated that the suppression might be due to an excess of L3T4+ Lyt-2-VOL. 54, 1986 on November 6, 2017 by guest http://iai.asm.org/ Downloaded from helper T cells (40) or colony-stimulating factors (29a). We present evidence in this report that progressive cutaneous leishmaniasis in BALB/c mice infected with L. major is accompanied by a depressed level of IL-2 production by spleen cells in response to ConA. These results are in agreement with and extend the findings of an earlier study (36) that abnormal phytohemagglutinin-induced spleen cell activation in BALB/c mice with L. donovani infection is associated with impaired production of IL-2. In addition, our data support an in vivo functional role for IL-2 in cutaneous leishmaniasis. Disease progression or regression was correlated with the IL-2-producing capacity of spleen cells from mice with cured infection or which had protective i.v. immunization or the deleterious s.c. injection with irradiated promastigotes. It seems unlikely, however, that IL-2 alone is capable of containing disease progression since four s.c. injections exacerbated the disease despite an initial capability of producing a relatively high level of IL-2.
A major finding of the present study was that depressed IL-2 production was not attributable to a primary defect in T cells but rather to the presence of a population of adherent suppressor cells whose suppressive activity could be reversed by a prostaglandin inhibitor, indomethacin. Adherent suppressor cells have been demonstrated in numerous systems (1, 3, 5, 15, 17, 33) . Several lines of the present evidence imply that the suppressor cells regulating IL-2 production are macrophages: (i) the suppressive activity was removed by treatment with carbonyl iron and passage through a Sephadex G-10 column, (ii) it was retained in the plastic-and Sephadex G-10-adherent fractions, and (iii) it was not modified by treatment with anti-Thy-1.2 antibody and complement. Nevertheless, the possibility was not formally excluded that the suppression observed was mediated by an adherent T cell population with a low density of Thy-1 antigen on its surface. It is unlikely, however, that depressed IL-2 production in spleen cell populations is due to a numerical reduction of IL-2-producing T cells. Although there is a significant increase in the percentage of macrophages (from 10 to 20%) among spleen cells after L. major infection (19) , there is little corresponding decrease in the percentage of L3T4+ T cells (our unpublished data), which are believed to be mainly responsible for IL-2 production (34). It is also unlikely that the suppresion is due to leishmanial antigens carried over by infected macrophages since the deliberate addition of live promastigotes or amastigotes into the NA-C + A-C culture did not lead to significant reduction of IL-2 production (data not shown).
Suppression of IL-2 production has been reported for several infectious disease systems. These include Trypanosoma cruzi (11) , Plasmodium berghei (20, 21) , and Histoplasma capsulatum (42) infection in mice and Mycobacterium leprae (32) infection in humans. It has been reported that an IL-2 suppressive factor is released by nonspecific T acceptor cells in the T suppressor circuit of the contact sensitivity system (28) . The present results show that IL-2 production by mitogen-stimulated T cells can also be suppressed by macrophages from mice infected with L. major. However, attempts to obtain evidence for the presence of a similar suppressor factor (10) were unsuccessful (data not shown).
The secretion of IL-2 by T cells can be influenced by IL-1 (39) . However, it is unlikely that the suppression of IL-2 production was caused by a deficiency of IL-1 in the present system since the PC of all mice tested produced normal or elevated levels of IL-1 in response to LPS. Furthermore, no correlation between IL-1 production and disease develop- ment was observed. Although we used peritoneal macrophages instead of spleen cells for IL-1 production, such production is consistently higher by spleen cells than by peritoneal exudate cells (21, 43) . Suppression of IL-2 production in murine trypanosomiasis (11) , histoplasmosis (42), malaria (21) , and clinical leprosy (32) has been shown to be IL-i independent.
Unlike acute malarial infection, in which depressed mitogen-induced proliferation can be fully restored by exogenous IL-2, the proliferation of ConA blasts from BALB/c mice with progressive L. major infection (100 days postinfection) was restored only minimally by exogenous IL-2 ( Table 2 ). This failure to mount a vigorous response to added IL-2 was apparently not due to the absence of an IL-2 receptor (as is the case for lepromatous leprosy) since the splenic T cells, in the absence of adherent cells, produced normal elvels of IL-2 (Table 4 ) and had an IL-2 receptor density similar to that of normal splenic T cells (our unpublished data). Adherent suppressor cells seem likely to affect the ability of T cells to respond to or release IL-2.
The action most commonly attributed to indomethacin is inhibition of prostaglandin synthetase; the importance of prostaglandins in regulation of the immune response has been well documented (8) . Prostaglandins are produced by activated macrophages (6) , and prostaglandin E2 (PGE2) can inhibit IL-2 production by human T cells (2, 35) . The increase in the production of PGE2 by macrophages at the height of infection is thought to be responsible for the generalized immunosuppression associated with African trypanosomiasis (4) and leishmaniasis (37) . In the present system, the suppressed IL-2 production by spleen cells from mice with progressive leishmaniasis was readily reversed by the addition of indomethacin. Thus, our results suggest that in fatal cutaneous leishmaniasis macrophages may secrete PGE2, which would in turn inhibit the production of IL-2,
